SARASOTA, Fla., Dec. 17, 2015 /PRNewswire-iReach/ — WellSpring Pharmaceutical Corporation today announced its acquisition of Bactine, the highly trusted first aid antiseptic brand.

On the market for over 65 years, Bactine has been a favorite of mothers for generations, bringing both pain relief for first aid injuries and an antiseptic that kill germs. It brings soothing skin protection for minor cuts, scrapes and burns.

Bactine is an excellent addition to the rapidly expanding personal care and OTC brand portfolio that WellSpring is building. Earlier this month, WellSpring announced its acquisition of FDS, a leading feminine hygiene brand. Only about one year ago, the company acquired Bonine, adding scale to its existing nausea franchise, teaming with Emetrol. WellSpring also markets Gelusil and Micatin along with a number of innovative personal care brands, including Glaxal Base skin moisturizers and Barriere™ silicone skin cream.

“We are very excited about the acquisition of Bactine,” said Wendy Shusko, CEO at WellSpring. “We believe there is a great deal of potential in this iconic brand and look forward to leveraging its heritage in the first aid category. It is a fantastic product that relieves pain on contact and unlike many other first aid products, does not sting. It is an excellent addition to our growing portfolio. Its broad distribution in all major drug, mass and food retailers gives us an excellent platform to build upon with innovative new products and programs.”

About WellSpring

Founded in 1999, WellSpring Pharmaceutical Corporation is a privately held company which manufactures and markets a portfolio of well-recognized OTC brands that are widely distributed throughout the U.S. and Canada. Its prescription drug portfolio consists of brands that are recognized as highly effective therapies for certain niche patient populations. In addition, WellSpring is a contract manufacturing organization serving well-known U.S. pharmaceutical companies. Its wholly owned subsidiary operates an FDA and Health Canada inspected manufacturing plant in Oakville, Ontario, Canada. In October 2011, WellSpring was acquired by Sentinel and Ancor in partnership with its management team. For more information, visit www.wellspringpharm.com.

About Sentinel Capital Partners

Founded in 1995 and based in New York City, Sentinel Capital Partners is a private equity firm that invests in promising companies at the lower end of the middle market. It targets investments in the following eight industry sectors: aerospace/defense, business services, consumer, distribution, food/restaurants, franchising, healthcare and industrials. For more information, visit www.sentinelpartners.com.

About Ancor Capital Partners

Based in Fort Worth, Texas Ancor Capital Partners is an operations-focused private equity firm that targets companies in the manufacturing, consumer and distribution sectors. For more information, visit www.ancorcapital.com.

Sawaya Segalas & Co., LLC acted as exclusive financial advisor to WellSpring on this transaction.

Media Contact: Rob HASSELMAN, WellSpring Pharmaceutical Corporation, 941-312-4727, rhasselman@wellspringpharm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

Photo – http://photos.prnewswire.com/prnh/20151216/296586

SOURCE WellSpring Pharmaceutical Corporation